Seelos Therapeutics is a clinical-stage biopharmaceutical company focused on the development of products that address unmet needs in Central Nervous System disorders and other disorders. Co.'s primary programs are SLS-002 for the potential treatment of Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder and SLS-005 for the potential treatment of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia. SLS-005 for the potential treatment of Sanfilippo Syndrome requires additional natural history data, which is being considered. Co. is also developing several preclinical programs, including SLS-004 and SLS-007, for the potential treatment of Parkinson's Disease. We show 21 historical shares outstanding datapoints in our SEEL shares outstanding history coverage, used to compute SEEL market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SEEL market cap history over the course of time is important for investors
interested in comparing SEEL's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SEEL versus a peer is one thing; comparing
SEEL market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SEEL can fluctuate over the course of history.
With this page we aim to empower investors researching SEEL by allowing them to research the SEEL market cap history. |
Free SEEL Email Alerts:
Video: The Importance of Market Cap
